Whole tissue lysates were prepared to determine troponin protein levels. Therefore, pulverized frozen tissue was homogenized in 40 μl/mg tissue 1× reducing sample buffer (106 mM Tris-HCl, 141 mM Tris-base, 2% lithium dodecyl sulfate (LDS), 10% glycerol, 0.51 mM EDTA, 0.22 mM SERVA Blue G250, 0.18 mM Phenol Red, 100 mM DTT) using a glass tissue grinder. Proteins were denatured by heating to 99 °C for 5 min and debris was removed by centrifugation at maximum speed for 10 min in a microcentrifuge (Sigma, 1–15 K).
For analysis of troponin protein levels by Western blot, 5 μg of protein were separated on a 4–15%
TGX gradient-gel (Biorad) and transferred to a polyvinylidene difluoride membrane. Site-specific antibodies directed to cTnT (
ab10214, Abcam), cTnT (
T6277, Sigma-Aldrich), cTnT (
ab8295, Abcam), cTnI (
ab10231, Abcam), cardiac Troponin C (cTnC, sc48347, Santa Cruz) and α-actinin (
A7811, Sigma-Aldrich) were used to detect the proteins which were visualized with an
enhanced chemiluminescence detection kit (Amersham) and scanned with
Amersham Imager 600. Protein levels were determined by densitometric analysis. Protein levels were normalized to α-actinin or cTnI when appropriate.
Equal loading of troponin complexes was verified with
Imperial protein stain (Thermo Scientific).
Schuldt M., Johnston J.R., He H., Huurman R., Pei J., Harakalova M., Poggesi C., Michels M., Kuster D.W., Pinto J.R, & van der Velden J. (2020). Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes. Journal of molecular and cellular cardiology, 150, 77-90.